Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - norethisterone, quantity: 1 mg; ethinylestradiol, quantity: 36 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; magnesium stearate - indications as at 31 august 1998 : contraception

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 36 microgram; norethisterone, quantity: 500 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; sunset yellow fcf; magnesium stearate; microcrystalline cellulose; lactose - indications as at 31 august 1998 : contraception

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 0.03 mg; levonorgestrel, quantity: 0.125 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; glycol montanate; sucrose; povidone; titanium dioxide; iron oxide yellow; calcium carbonate; glycerol; purified talc; macrogol 6000 - indicated for the prevention of pregnancy.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 0.03 mg; gestodene, quantity: 0.075 mg - tablet, sugar coated - excipient ingredients: brilliant scarlet 4r; magnesium stearate; macrogol 6000; calcium carbonate; lactose monohydrate; erythrosine; purified talc; maize starch; sucrose; glycol montanate; povidone - for the prevention of pregnancy.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - levonorgestrel, quantity: 0.15 mg; ethinylestradiol, quantity: 0.03 mg - tablet, sugar coated - excipient ingredients: erythrosine; maize starch; glycol montanate; sucrose; brilliant scarlet 4r; macrogol 6000; lactose monohydrate; purified talc; povidone; magnesium stearate; calcium carbonate - nordette is indicated for the prevention of pregnancy.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - levonorgestrel, quantity: 0.15 mg; ethinylestradiol, quantity: 0.03 mg - tablet, sugar coated - excipient ingredients: povidone; lactose monohydrate; magnesium stearate; erythrosine; sucrose; purified talc; macrogol 6000; calcium carbonate; maize starch; brilliant scarlet 4r; glycol montanate - indicated for the prevention of pregnancy.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 20 microgram; levonorgestrel, quantity: 100 microgram - tablet, film coated - excipient ingredients: lactose monohydrate; macrogol 1500; magnesium stearate; microcrystalline cellulose; glycol montanate; polacrilin potassium; titanium dioxide; hypromellose; hyprolose; macrogol 400 - 1. the prevention of pregnancy. 2. the treatment of moderate acne vulgaris not controlled with topical preparations in post-menarchal, pre-menopausal women who accept contraception.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ethinylestradiol, quantity: 0.03 mg; levonorgestrel, quantity: 0.125 mg - tablet, sugar coated - excipient ingredients: glycerol; calcium carbonate; glycol montanate; purified talc; macrogol 6000; povidone; lactose monohydrate; iron oxide yellow; magnesium stearate; maize starch; titanium dioxide; sucrose - triphasil is indicated for the prevention of pregnancy.

Panama - engelsk - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

organon (ireland) ltd - estradiol (hemihidrato) - estradiol (hemihidrato)....1.50 mg / acetato de nomegestrol....2.50 mg

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - bella is indicated for use:,? as an oral contraceptive.,? for the treatment of moderate acne vulgaris in women who seek oral contraception.,? for the treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of ethinylestradiol/drospirenone 20 microgram/3 mg tablets for pmdd was not assessed beyond 3 cycles. ethinylestradiol/drospirenone 20 microgram/3 mg tablets have not been evaluated for treatment of pms (premenstrual syndrome) (see section 5.1 pharmacodynamic properties ? clinical trials).